Protection of vaccinia‐primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160
- 1 February 1993
- journal article
- research article
- Published by Wiley in Journal of Medical Primatology
- Vol. 22 (2-3) , 92-99
- https://doi.org/10.1111/j.1600-0684.1993.tb00645.x
Abstract
No abstract availableKeywords
Funding Information
- U.S. Public Health Service
- National Institutes of Health (RR00166)
This publication has 23 references indexed in Scilit:
- Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical TrialThe Journal of Infectious Diseases, 1992
- Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160Science, 1992
- The Ability of Certain SIV Vaccines to Provoke Reactions Against Normal CellsScience, 1992
- Cross-Neutralizing Antibodies in Rabbits Immunized with HIV-1 gp160 Purified from Simian Cells Infected with a Recombinant Vaccinia VirusAIDS Research and Human Retroviruses, 1991
- In Vitro Assays for Detecting Neutralizing and Fusion-Inhibiting Antibodies to SIVMAC251AIDS Research and Human Retroviruses, 1991
- Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virusVaccine, 1991
- SIV vaccines, 1991—a year in reviewAIDS, 1991
- T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia virusesNature, 1986
- Expression of AIDS virus envelope gene in recombinant vaccinia virusesNature, 1986
- Recombinant Vaccinia Virus: Immunization Against Multiple PathogensScience, 1985